Sequentify

📍 Rehovot, Israel🗓 Founded 2021👥 14 employees💰 Last funded May 2021
Biotechnology🌐 sequentify.com
Website LinkedIn
At Sequentify, we empower genomic labs to achieve scalable, population-wide genomic sequencing through our innovative solutions. Our technology is designed to decentralize genomic testing by addressing the industrys top three challenges: sample preparation, result analysis, and cost reduction. Our end-to-end solution offers unmatched scalability, automation friendliness, and cost-effectiveness, making it ideal for diverse applications, including cancer diagnostics, carrier screening, and infectious disease. Currently raising our Series A round, as we aim to accelerate growth.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2021
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Israel
1
Frequently asked questions
Who invested in Sequentify?
Sequentify has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Sequentify last raise funding?
The most recent investment in Sequentify recorded on gritt.io was in May 2021.
When was Sequentify founded?
Sequentify was founded in 2021.
What industry is Sequentify in?
Sequentify operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Sequentify based?
Sequentify is headquartered in Rehovot, Israel.